Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.
Novoron Bioscience has raised $2.5M in total funding. The most recent round was Grant. The last funding was announced in January 2026.
Novoron Bioscience's investors include Two Bear Capital, National Institutes of Health, Backstage Capital, National Institute on Aging.
Novoron Bioscience is headquartered in San Diego, United States.
Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.
Novoron Bioscience is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Novoron Bioscience — Funding & Investors." VCBacked, January 6, 2026, https://www.vcbacked.co/company/novoron-bioscience. Accessed July 19, 2026.
VCBacked. (2026). Novoron Bioscience — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/novoron-bioscience
{{cite web |title=Novoron Bioscience — Funding & Investors |url=https://www.vcbacked.co/company/novoron-bioscience |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated